Beihua H. Kong - Publications

Folate Receptor Alpha Expression Across the Spectrum of Serous Tubal Lesions: An Adjunct Biomarker for Distinguishing Serous Tubal Intraepithelial Carcinoma From Serous Tubal Intraepithelial Lesions.

Journal: The American journal of surgical pathology

Published: June 25, 2026

Clinical and Prognostic Significance of a Squamous Cell Carcinoma Component in Endometrioid Endometrial Carcinoma: A Multicenter Retrospective Cohort Study.

Journal: Cancers

Published: May 29, 2026

Development of a prediction model for recurrence in patients with malignant ovarian germ cell tumors undergoing fertility-sparing surgery: A multicenter retrospective study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 20, 2026

Overall survival and long-term safety of olaparib maintenance in patients with platinum-sensitive relapsed ovarian cancer: final analyses of phase III L-MOCA trial.

Journal: Journal of ovarian research

Published: February 10, 2026

The prognostic value of surgery in patients with locally advanced vulvar cancer: results from the SEER database and a Chinese multicenter registry.

Journal: Journal of gynecologic oncology

Published: October 16, 2025

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Journal: The New England journal of medicine

Published: October 15, 2025

Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial.

Journal: Therapeutic advances in medical oncology

Published: September 21, 2025

The prognostic and clinical significance of cervical stromal invasion in endometrial cancer: a multicenter retrospective study.

Journal: American journal of obstetrics and gynecology

Published: September 16, 2025

Association between tumor laterality and prognosis across different ovarian cancer subtypes: Results from SEER database and a Chinese multicenter cohort.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 15, 2025

Spliceosomal component SNRPE drives cell proliferation by regulating CTP synthase 1 mRNA splicing in ovarian cancer.

Journal: Oncogene

Published: August 23, 2025

Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study.

Journal: Therapeutics and clinical risk management

Published: March 31, 2025

5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications.

Journal: Journal of ovarian research

Published: March 21, 2025